Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders
- PMID: 32439401
- DOI: 10.1016/j.jaac.2020.05.005
Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders
Abstract
Anxiety disorders are among the most common psychiatric disorders in children and adolescents. As reviewed in this guideline, both cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitor (SSRI) medication have considerable empirical support as safe and effective short-term treatments for anxiety in children and adolescents. Serotonin norepinephrine reuptake inhibitor (SNRI) medication has some empirical support as an additional treatment option. In the context of a protracted severe shortage of child and adolescent-trained behavioral health specialists, research demonstrating convenient, efficient, cost-effective, and user-friendly delivery mechanisms for safe and effective treatments for child and adolescent anxiety disorders is an urgent priority. The comparative effectiveness of anxiety treatments, delineation of mediators and moderators of effective anxiety treatments, long-term effects of SSRI and SNRI use in children and adolescents, and additional evaluation of the degree of suicide risk associated with SSRIs and SNRIs remain other key research needs.
Keywords: anxiety; assessment; child psychiatry; clinical practice guideline; treatment.
Copyright © 2020. Published by Elsevier Inc.
Similar articles
-
Advances in Pharmacotherapy for Pediatric Anxiety Disorders.Child Adolesc Psychiatr Clin N Am. 2023 Jul;32(3):573-587. doi: 10.1016/j.chc.2023.02.006. Epub 2023 Mar 28. Child Adolesc Psychiatr Clin N Am. 2023. PMID: 37201968 Review.
-
Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Major and Persistent Depressive Disorders.J Am Acad Child Adolesc Psychiatry. 2023 May;62(5):479-502. doi: 10.1016/j.jaac.2022.10.001. Epub 2022 Oct 21. J Am Acad Child Adolesc Psychiatry. 2023. PMID: 36273673
-
Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.Nord J Psychiatry. 2023 Feb;77(2):137-146. doi: 10.1080/08039488.2022.2075460. Epub 2022 May 19. Nord J Psychiatry. 2023. PMID: 35587815
-
Comparative effectiveness of cognitive behavioral treatment, serotonin, and serotonin noradrenaline reuptake inhibitors for anxiety in children and adolescents: a network meta-analysis.Nord J Psychiatry. 2023 Feb;77(2):118-126. doi: 10.1080/08039488.2022.2069858. Epub 2022 May 4. Nord J Psychiatry. 2023. PMID: 35507829 Review.
-
Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.J Clin Psychopharmacol. 2017 Jun;37(3):332-340. doi: 10.1097/JCP.0000000000000701. J Clin Psychopharmacol. 2017. PMID: 28383363
Cited by
-
Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022.Pediatrics. 2024 Mar 1;153(3):e2023064245. doi: 10.1542/peds.2023-064245. Pediatrics. 2024. PMID: 38404197
-
The definition of treatment resistance in anxiety disorders: a Delphi method-based consensus guideline.World Psychiatry. 2024 Feb;23(1):113-123. doi: 10.1002/wps.21177. World Psychiatry. 2024. PMID: 38214637 Free PMC article.
-
Common Issues for General Practitioners in the Medical Management of Child and Adolescent Psychiatric Care.J Pediatr Pharmacol Ther. 2023;28(7):595-602. doi: 10.5863/1551-6776-28.7.595. Epub 2023 Nov 23. J Pediatr Pharmacol Ther. 2023. PMID: 38025144 Free PMC article.
-
Immersive Virtual Reality Exposures for the Treatment of Childhood Anxiety.Child Psychiatry Hum Dev. 2023 Nov 20. doi: 10.1007/s10578-023-01628-4. Online ahead of print. Child Psychiatry Hum Dev. 2023. PMID: 37985621
-
Trends in prescription therapy for adolescents with depression in nine major areas of China during 2017-2021.Front Psychiatry. 2023 Oct 26;14:1175002. doi: 10.3389/fpsyt.2023.1175002. eCollection 2023. Front Psychiatry. 2023. PMID: 37953934 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials